Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations

Marco Bongiovanni; Paul Thoueille; Beatrice Barda; Thomas Mercier; Catia Marzolini; Niccolò Ramponi; Eva Choong; Marco Cantù; Laurent A Decosterd; Enos Bernasconi

doi:10.1007/s10096-024-04844-5

Oritavancin use in patients with recurrent bone infections by methicillin-resistant Staphylococcus aureus with monitoring of concentrations

Eur J Clin Microbiol Infect Dis. 2024 Jul;43(7):1503-1504. doi: 10.1007/s10096-024-04844-5. Epub 2024 May 14.

Authors

Marco Bongiovanni^{1

2}, Paul Thoueille^{3

4}, Beatrice Barda^{5

4}, Thomas Mercier^{3

4}, Catia Marzolini^{3

4}, Niccolò Ramponi^{5

4}, Eva Choong^{3

4}, Marco Cantù^{4

6}, Laurent A Decosterd^{3

4}, Enos Bernasconi^{5

4

7

8}

Affiliations

¹ Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland. Marco.Bongiovanni@eoc.ch.
² Division of Infectious Diseases and Hospital Epidermiology, University Hospital Basel, Basel, Switzerland. Marco.Bongiovanni@eoc.ch.
³ Service and Laboratory of Clinical Pharmacology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
⁴ Division of Infectious Diseases and Hospital Epidermiology, University Hospital Basel, Basel, Switzerland.
⁵ Division of Infectious Diseases, Ente Ospedaliero Cantonale, Lugano, Switzerland.
⁶ Istituto di Medicina di Laboratorio EOLAB Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
⁷ University of Geneva, Geneva, Switzerland.
⁸ University of Southern Switzerland, Lugano, Switzerland.

PMID: 38740656
DOI: 10.1007/s10096-024-04844-5

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Anti-Bacterial Agents* / therapeutic use
Drug Monitoring
Female
Humans
Lipoglycopeptides* / therapeutic use
Male
Methicillin-Resistant Staphylococcus aureus* / drug effects
Methicillin-Resistant Staphylococcus aureus* / isolation & purification
Microbial Sensitivity Tests
Middle Aged
Osteomyelitis / drug therapy
Osteomyelitis / microbiology
Recurrence
Staphylococcal Infections* / drug therapy
Staphylococcal Infections* / microbiology
Vancomycin / analogs & derivatives

Substances

Lipoglycopeptides
oritavancin
Anti-Bacterial Agents
Vancomycin